Quality control and standardization of FACA® syrup

Salfo Ouedraogo, Sidiki Traoré, Jean Claude W. Ouédraogo, Moumouni Koala, Lazare Belemnaba, Noufou Ouédraogo, Felix Kini, Sylvin Ouédraogo, Innocent Pierre Guissou

DOI: http://dx.doi.org/10.5138/09750215.2166


Sickle cell disease is a major public health problem. It is the first genetic disease in the world. FACA syrup offers an alternative treatment. It is a dry powder preparation of two components, the roots barks of Zanthoxylum zanthoxyloides Lam. (Rutaceae) Zepernick, Timler and Calotropis procera. Ait. R.B.r. (Asclepiadaceae). The product was developed at Institute for Research in Health Sciences (IRSS) from a traditional recipe used in Burkina Faso for treatment of sickle cell crises. This study aimed to establish physical-chemical, pharmaco technical and microbiological control parameters essential for the standardization of the phytomedicine. This valuation concerned specifications of moisture content, pH, the fingerprint by thin layer chromatography, pesticide residues, heavy metal content, microbial quality, and total ash. These charcteristics were determined by the methods prescribed by the World Health Organization (1998) and the European Pharmacopoeia 6th edition. The results have shown that dry syrups and reconstituted syrups were sweet, slightly spicy with a bitter after taste, a white room color and a faint odor. The density at the preparation was 0.985 and the pH was 5.93. After 2 months of storage in the laboratory, the organoleptic parameters of the reconstituted syrups have not changed. They were mold free, the density remained around 1 and the pH between 5 and 4. These parameters have shown that the quality of plants powders and these medicine comply with the recommendations of the European pharmacopoeia. Faca syrup may contribute to the better management of sickle cell disease in children.


FACA syrup, sickle cell disease, plant powder, medicinal plant, quality control


Coppieters, M., et al., Analyse qualitative de l'offre pour la prévention et la prise en charge de la drépanocytose à Bruxelles. Revue Medicale de Bruxelles-Nouvelle Serie, 2011. 32(3): p. 139. 2. Nikiema, J.B., et al., Promotion de la medecine traditionnelle au Burkina Faso: Essai de developpement d’un medicament antidrepanocytaire, le FACA. The African Health Monitor (WHO Publication), 2010. 3. Piel, F.B., et al., Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. The Lancet, 2013. 381(9861): p. 142-151. 4. Grosse, S.D., et al., Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality. Am J Prev Med, 2011. 41(6): p. S398-405. 5. Meier, E.R. and J.L. Miller, Sickle Cell Disease in Children. Drugs, 2012. 72(7): p. 895-906. 6. Raskin, I., et al., Plants and human health in the twenty-first century. TRENDS in Biotechnology, 2002. 20(12): p. 522-531. 7. WHO, Traditional medicine strategy 2002-2005. 2002. 74. 8. Ouattara, B., et al., LC/MS/NMR analysis of isomeric divanilloylquinic acids from the root bark of Fagara zanthoxyloides Lam. Phytochemistry, 2004. 65(8): p. 1145-1151. 9. Ouattara, B., et al., Antisickling properties of divanilloylquinic acids isolated from Fagara zanthoxyloides Lam. (Rutaceae). Phytomedicine, 2009. 16(2-3): p. 125-9. 10. Guissou, I., et al., Etude de l'efficacité antidrépanocitaire de gélules FACA chez les enfants en milieu hospitalier de Ouagadougou (CHN-YO). Pharm. Méd. trad. afro, 1995: p. 29-36. 11. Ouédraogo, J.C.W., et al., Standardisation de la poudre des écorces de racine de Zanthoxylum zanthoxyloides en vue la production d'un phytomédicament anti-drépanocytaire pédiatrique/Standardization of bark root powder of Zanthoxylum zanthoxyloides for the production of pediatric phytomedecine against Sickle Cell Disease. Journal de la Société Ouest-Africaine de Chimie, 2015. 40: p. 24. 12. Adesina, S., The Nigerian Zanthoxylum; chemical and biological values. 2005. 13. Européenne, P., Guide pour l’élaboration des monographies de drogues végétales et préparations à base de drogues végétales. . Direction Européenne de la Qualité du Médicament & Soins de Santé., ed. S.C. Conseil de l’Europe, France. 2007. 74. 14. Babich, H. and G. Stotzky, Effect of cadmium on fungi and on interactions between fungi and bacteria in soil: influence of clay minerals and pH. Applied and environmental microbiology, 1977. 33(5): p. 1059-1066. 15. WHO, Réglementation des médicaments à base de plantes: la situation dans le monde. 1998: p. 65. 16. Chiffoleau, J.-F., D. Auger, and E. Chartier, Dosage de certains métaux traces:(Cd, Co, Cu, Fe, Ni, Pb, Zn) dissous dans l'eau de mer par absorption atomique après extraction liquide-liquide. 2002: Editions Quae.


  • There are currently no refbacks.

Copyright (c) 2017 Salfo OUEDRAOGO

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Advanced Research Journals

18K, Street 1st, Gaytri Vihar, Pinto Park, Gwalior, M.P. India

Copyright@arjournals.org (Design) 2009-2016


Follow @arjournals on Twitter